Lucyna Cova

Lyon, 69003, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.

Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.

Journal: Biomolecules

Published: June 14, 2018

Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication.

Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication.

Journal: Molecular therapy. Nucleic acids

Published: August 01, 2017

Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks.

Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks.

Journal: Hepatology (Baltimore, Md.)

Published: July 28, 2017

Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.

Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.

Journal: Molecular therapy. Nucleic acids

Published: January 19, 2017

Present and future DNA vaccines for chronic hepatitis B treatment.

Present and future DNA vaccines for chronic hepatitis B treatment.

Journal: Expert opinion on biological therapy

Published: November 29, 2016

Therapeutic Potential of Cell Penetrating Peptides (CPPs) and Cationic Polymers for Chronic Hepatitis B.

Therapeutic Potential of Cell Penetrating Peptides (CPPs) and Cationic Polymers for Chronic Hepatitis B.

Journal: International journal of molecular sciences

Published: September 30, 2015

Advances and challenges in the development of therapeutic DNA vaccines against hepatitis B virus infection.

Advances and challenges in the development of therapeutic DNA vaccines against hepatitis B virus infection.

Journal: Current gene therapy

Published: December 18, 2013

Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.

Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.

Journal: Bioorganic & medicinal chemistry letters

Published: November 11, 2013

Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island.

Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island.

Journal: Hepatology (Baltimore, Md.)

Published: November 09, 2012

Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide.

Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide.

Journal: PloS one

Published: July 26, 2012

In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.

In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.

Journal: Journal of viral hepatitis

Published: June 26, 2012

In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins.

In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins.

Journal: Virology

Published: April 11, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026